Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory Factors and Immune Function

Table 3

Comparison of tumor markers between the two groups.

Groups		UBC (μg/L)				NMP-22 (U/mL)
		Before treatment	After treatment			Before treatment	After treatment
Combination group	21			12.328	<0.001			15.145	<0.001
GT group	21			7.311	<0.001			8.527	<0.001
		0.219	5.821			0.150	5.414
		0.615	<0.001			0.821	<0.001